The Inserm-University of Bordeaux study, published in Nature Neuroscience and using targeted mitoDreadd-Gs receptor activation in mouse models of dementia, establishes a causal role for mitochondrial impairment in cognitive decline rather than a downstream effect. Unlike prior observational work linking energy failure to Alzheimer's plaques, this approach temporarily boosted G-protein signaling inside mitochondria to restore neuronal communication and memory performance. Sample sizes were modest, typical of early preclinical designs, with limitations including short-term activation only and lack of long-term safety data in larger mammals. What mainstream coverage overlooks is the direct tie to aging trajectories: mitochondrial dysfunction accelerates across decades in human brains, preceding overt neurodegeneration as seen in longitudinal cohorts from the Alzheimer's Disease Neuroimaging Initiative. This reframes therapies away from amyloid clearance toward proactive energy restoration, potentially intersecting with Parkinson's research where similar mitochondrial toxins drive early synaptic failure. A 2023 review in Nature Reviews Neuroscience and a 2024 Cell Metabolism paper on neuronal bioenergetics support this pattern, highlighting how energy shortages impair synaptic plasticity before cell death.